[Statin-associated muscle symptoms: epidemiology, risk factors, mechanisms and treatment] [0.03%]
他汀类相关肌肉症状的流行病学、风险因素、机制和治疗措施
A I Dyadyk,T E Kugler,S R Zborowskyy et al.
A I Dyadyk et al.
Statins are widely prescribed and the risk of adverse drug reactions of lipid-lowering therapy is actively discussed, including muscle symptoms. This review synthesizes the knowledge about the clinical aspects of statin-associated muscle sy...
[Complications of the Catheter Treatment of Atrial Fibrillation: Stenosis of All Pulmonary Veins after Radiofrequency Ablation] [0.03%]
导管消融后肺静脉狭窄的原因及处理
E V Merkulov,O V Sapelnikov,E E Vlasova et al.
E V Merkulov et al.
Radiofrequency ablation is the "gold standard" in atrial fibrillation treatment. The frequency of complications is about 3.5-3.9 %. The symptomatic pulmonary vein stenosis is one of the most severe complications. In this report we present a...
O N Antropova,I V Osipova
O N Antropova
The review contains results of analysis of clinical studies on the problem of defining the target level of the blood pressure (BP). The rationale for selection the target systolic BP level below120 mmHg was obtained in the SPRINT study comp...
[Antithrombotic Therapy in Atrial Fibrillation and Chronic Ischemic Heart Disease] [0.03%]
房颤合并慢性缺血性心脏病的抗栓治疗
A Yu Rychkov,N Yu Khorkova
A Yu Rychkov
The review is devoted to the use of antithrombotic therapy in patients with atrial fibrillation (AF) and chronic ischemic heart disease (IHD). We discuss data of international registries, meta-analyses assessing possibilities of the use of ...
[Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart Rhythm Association Practical Guide)] [0.03%]
《房颤患者使用新型口服抗凝药物的建议（基于2018年欧洲心律协会实践指南）》
L V Popova,T B Kondratieva,M B Aksenova et al.
L V Popova et al.
Non-vitamin K antagonist oral anticoagulants (NOACs) - direct oral anticoagulants - are getting the ever-broadening use in clinical practice. However, many problems related to optimal use of NOACs in specific clinical situations remain unre...
Article Editorial
Article Editorial
[Markers of Vascular Wall Fibrosis Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Ischemic Heart Disease with and without Concomitant Type-2 Diabetes Mellitus] [0.03%]
缺血性心脏病并存2型糖尿病患者血管壁成纤维细胞标记物金属蛋白酶9及金属蛋白酶组织抑制剂1的变化研究
Y N Belenkov,E V Privalova,A O Iusupova et al.
Y N Belenkov et al.
The prevalence of ischemic heart disease (IHD) and diabetes mellitus type 2 (DM type 2) is permanently increasing both worldwide and in theRussian Federation. That is why studies of mechanisms of pathogenesis of both diseases is continuing ...
[Epicardial Transplantation of Cardiac Progenitor Cells Based Cells Sheets is More Promising Method for Stimulation of Myocardial Regeneration, Than Conventional Cell Injections] [0.03%]
基于细胞 sheet 的 epicardium 移植比常规细胞注射更能够促进心肌再生
K V Dergilev,Z I Tsokolayeva,I B Beloglazova et al.
K V Dergilev et al.
Today, transplantation of stem / progenitor cells is a promising approach for the treatment of heart diseases. The therapeutic potential of transplanted cells directly depends on the method of delivery to the myocardium, which determines th...
[Carotid Wall Shear Rate as a Marker of Systemic Atherosclerosis and Atherosclerotic Cardiovascular Disease] [0.03%]
[以颈动脉剪切率为系统性动脉粥样硬化和动脉粥样硬化心血管疾病的标志]
V V Genkel,I I Shaposhnik
V V Genkel
Aim: to assess possibility of the use of carotid wall shear rate (WSR) as a marker of systemic atherosclerosis and atherosclerotic cardiovascular disease (ASCVD). ...
[Predictors of Progressive Course of Multifocal Atherosclerosis in Patients With Myocardial Infarction] [0.03%]
[多灶性动脉粥样硬化患者心肌梗死后进展的预测因素]
D Yu Sedykh,A N Kazantsev,R S Tarasov et al.
D Yu Sedykh et al.
Purpose: Determination of clinical and instrumental predictors of progressive course of multifocal atherosclerosis (MFA) in patients one year after myocardial infarction (MI), initially having hemodynamically insignifican...